$BCOV
Brightcove Inc

2024 Q3 Form 10-Q Financial Statement

#000095017024093337 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $49.25M
YoY Change -3.41%
Cost Of Revenue $19.41M
YoY Change 4.9%
Gross Profit $29.84M
YoY Change -8.15%
Gross Profit Margin 60.59%
Selling, General & Admin $25.90M
YoY Change -8.92%
% of Gross Profit 86.8%
Research & Development $8.975M
YoY Change -13.24%
% of Gross Profit 30.08%
Depreciation & Amortization $5.167M
YoY Change 27.3%
% of Gross Profit 17.32%
Operating Expenses $34.88M
YoY Change -10.07%
Operating Profit -$5.037M
YoY Change -20.01%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $49.00K
YoY Change -88.39%
Pretax Income -$4.988M
YoY Change -15.74%
Income Tax $257.0K
% Of Pretax Income
Net Earnings -$5.245M
YoY Change -15.91%
Net Earnings / Revenue -10.65%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.12
COMMON SHARES
Basic Shares Outstanding 44.92M 44.58M
Diluted Shares Outstanding 44.73K

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.17M
YoY Change 26.59%
Cash & Equivalents $24.17M
Short-Term Investments
Other Short-Term Assets $10.26M
YoY Change -53.97%
Inventory
Prepaid Expenses $9.525M
Receivables $28.21M
Other Receivables $0.00
Total Short-Term Assets $72.16M
YoY Change 1.31%
LONG-TERM ASSETS
Property, Plant & Equipment $38.88M
YoY Change -35.84%
Goodwill $74.86M
YoY Change 0.0%
Intangibles $4.524M
YoY Change -45.12%
Long-Term Investments
YoY Change
Other Assets $4.719M
YoY Change -24.92%
Total Long-Term Assets $140.9M
YoY Change -6.07%
TOTAL ASSETS
Total Short-Term Assets $72.16M
Total Long-Term Assets $140.9M
Total Assets $213.0M
YoY Change -3.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.492M
YoY Change -58.79%
Accrued Expenses $19.92M
YoY Change -18.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $98.93M
YoY Change -9.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $192.0K
YoY Change -99.04%
Total Long-Term Liabilities $192.0K
YoY Change -99.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $98.93M
Total Long-Term Liabilities $192.0K
Total Liabilities $118.1M
YoY Change -8.88%
SHAREHOLDERS EQUITY
Retained Earnings -$236.6M
YoY Change 3.77%
Common Stock $45.00K
YoY Change 4.65%
Preferred Stock
YoY Change
Treasury Stock (at cost) $871.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $94.94M
YoY Change
Total Liabilities & Shareholders Equity $213.0M
YoY Change -3.69%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$5.245M
YoY Change -15.91%
Depreciation, Depletion And Amortization $5.167M
YoY Change 27.3%
Cash From Operating Activities $4.021M
YoY Change -62.8%
INVESTING ACTIVITIES
Capital Expenditures $2.187M
YoY Change -40.55%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.187M
YoY Change -40.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 4.021M
Cash From Investing Activities -2.187M
Cash From Financing Activities 0.000
Net Change In Cash 1.834M
YoY Change -74.17%
FREE CASH FLOW
Cash From Operating Activities $4.021M
Capital Expenditures $2.187M
Free Cash Flow $1.834M
YoY Change -74.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001313275
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35429
dei Entity Registrant Name
EntityRegistrantName
BRIGHTCOVE INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1579162
dei Entity Address Address Line1
EntityAddressAddressLine1
281 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
882-1880
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
BCOV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44921558
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24170000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18615000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
268000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
210000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28207000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33451000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9525000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6569000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
10255000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11764000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
72157000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
70399000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38882000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42476000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17896000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16233000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4524000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6368000
CY2024Q2 us-gaap Goodwill
Goodwill
74859000
CY2023Q4 us-gaap Goodwill
Goodwill
74859000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4719000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5772000
CY2024Q2 us-gaap Assets
Assets
213037000
CY2023Q4 us-gaap Assets
Assets
216107000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6492000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14422000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19918000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17566000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4261000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4486000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68255000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68155000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
98926000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
104629000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18983000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17358000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
192000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
207000
CY2024Q2 us-gaap Liabilities
Liabilities
118101000
CY2023Q4 us-gaap Liabilities
Liabilities
122194000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45047696
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43833919
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44912696
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43698919
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
45000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
44000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
334269000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
328918000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
135000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
135000
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
871000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
871000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1894000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1236000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236613000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-232942000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
94936000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
93913000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213037000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216107000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49247000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
50988000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
99728000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
100051000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19407000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18501000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39029000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38768000
CY2024Q2 us-gaap Gross Profit
GrossProfit
29840000
CY2023Q2 us-gaap Gross Profit
GrossProfit
32487000
us-gaap Gross Profit
GrossProfit
60699000
us-gaap Gross Profit
GrossProfit
61283000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8975000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10345000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17824000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20211000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17080000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19034000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33534000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38499000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8822000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9405000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18366000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19469000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
45000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
190000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
34877000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
38829000
us-gaap Operating Expenses
OperatingExpenses
63724000
us-gaap Operating Expenses
OperatingExpenses
78369000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5037000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6342000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3025000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17086000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
49000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
422000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4988000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5920000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3014000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17207000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
257000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
657000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
744000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-5245000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6237000
us-gaap Net Income Loss
NetIncomeLoss
-3671000
us-gaap Net Income Loss
NetIncomeLoss
-17951000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44731
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44731
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43059
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43059
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44357
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44357
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42795
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42795
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-5245000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6237000
us-gaap Net Income Loss
NetIncomeLoss
-3671000
us-gaap Net Income Loss
NetIncomeLoss
-17951000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-351000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-658000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
158000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5596000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6267000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4329000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17793000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
94936000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
91600000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
94936000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
91600000
us-gaap Net Income Loss
NetIncomeLoss
-3671000
us-gaap Net Income Loss
NetIncomeLoss
-17951000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10084000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8008000
us-gaap Share Based Compensation
ShareBasedCompensation
5372000
us-gaap Share Based Compensation
ShareBasedCompensation
7030000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-16000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
222000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5087000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4219000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1035000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1882000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-970000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-802000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7531000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3376000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2438000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5474000
bcov Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-262000
bcov Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-174000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
612000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8440000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6048000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1822000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
6000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1157000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1328000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4029000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
7233000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
814000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8561000
bcov Payments For Deferred Acquisition Payments
PaymentsForDeferredAcquisitionPayments
-0
bcov Payments For Deferred Acquisition Payments
PaymentsForDeferredAcquisitionPayments
1700000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-239000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-256000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-239000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1956000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1068000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-462000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5555000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12801000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18615000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31894000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24170000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19093000
us-gaap Operating Lease Payments
OperatingLeasePayments
1891000
us-gaap Operating Lease Payments
OperatingLeasePayments
1804000
us-gaap Income Taxes Paid
IncomeTaxesPaid
731000
us-gaap Income Taxes Paid
IncomeTaxesPaid
821000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
210000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
138000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
7000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
73000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
268000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24800000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
57300000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
17000000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
47600000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
11000000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
13100000
CY2024Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2700000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5800000
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2500000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5000000
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
24170000
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24170000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
18615000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
18615000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.048
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.048
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.479
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.555
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.479
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.555
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
22600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M7D
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3159000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3487000
us-gaap Share Based Compensation
ShareBasedCompensation
5372000
us-gaap Share Based Compensation
ShareBasedCompensation
7030000
CY2024Q2 us-gaap Revenues
Revenues
49247000
CY2023Q2 us-gaap Revenues
Revenues
50988000
us-gaap Revenues
Revenues
99728000
us-gaap Revenues
Revenues
100051000
CY2024Q2 bcov Percentage Of Revenue
PercentageOfRevenue
0.10
bcov Percentage Of Revenue
PercentageOfRevenue
0.10
CY2023Q2 bcov Percentage Of Revenue
PercentageOfRevenue
0.10
bcov Percentage Of Revenue
PercentageOfRevenue
0.10
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
400000
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
500000
us-gaap Restructuring Charges
RestructuringCharges
2100000
CY2024Q1 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
200000
CY2024Q2 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
0
CY2024Q1 bcov Proceeds From Sale Of Patents
ProceedsFromSaleOfPatents
6000000
CY2024Q2 bcov Proceeds From Sale Of Patents
ProceedsFromSaleOfPatents
0
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 bcov Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q2 bcov Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-093337-index-headers.html Edgar Link pending
0000950170-24-093337-index.html Edgar Link pending
0000950170-24-093337.txt Edgar Link pending
0000950170-24-093337-xbrl.zip Edgar Link pending
bcov-20240630.htm Edgar Link pending
bcov-20240630.xsd Edgar Link pending
bcov-ex31_1.htm Edgar Link pending
bcov-ex31_2.htm Edgar Link pending
bcov-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
bcov-20240630_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending